Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is...
evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(3023)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Nov 06, 2023 7:10pm
Revive Therapeutics Worldwide Exclusive Agreement
Potential world-first patented biomarker for long COVID Evaluating diagnostic companion with Bucillamine for long COVID TORONTO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive
...more
(5)
•••
1ottrunner
X
View Profile
View Bullboard History
Comment by
1ottrunner
on Nov 03, 2023 10:38pm
RE:Enters into Agreement with Defence Research and Development
Are you still holding Emo? You moron. Everyone here, and anyone following Cool888: He is 1 of 2 things. 1. a terrible investor, holding losing stocks. ( which not I almost doubt ) 2. a pumper
...more
(19)
•••
newonthestreet
X
View Profile
View Bullboard History
Post by
newonthestreet
on Nov 03, 2023 1:33pm
Will
This company EVER amount to anything or accomplish.anything?
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 17, 2023 7:11am
Enters into Agreement with Defence Research and Development
#Bucillamine https://ca.finance.yahoo.com/news/revive-therapeutics-enters-agreement-defence-110000524.html
(19)
•••
newonthestreet
X
View Profile
View Bullboard History
Post by
newonthestreet
on Oct 06, 2023 7:22pm
What
A piece of dog shite!!
(501)
•••
Traderstock101
X
View Profile
View Bullboard History
Post by
Traderstock101
on Aug 25, 2023 2:24pm
WoW! RVV GAP-UP no sellers at 0.06¢ $$$$$$$$$$$
Day Trader sell at 0.10¢ soon. https://www.cboe.ca/en/live/security-activity/RVV#!/market-depth
(501)
•••
Traderstock101
X
View Profile
View Bullboard History
Post by
Traderstock101
on Aug 25, 2023 1:13pm
Revive begins developing bucillamine formulation.
Mr. Michael Frank reports REVIVE THERAPEUTICS ANNOUNCES INITIATION OF NOVEL BUCILLAMINE FORMULATION DEVELOPMENT Revive Therapeutics Ltd. has initiated the development of a next-generation
...more
(501)
•••
Traderstock101
X
View Profile
View Bullboard History
Post by
Traderstock101
on Aug 25, 2023 1:11pm
The big investors bought at 0.05¢ and will all sell at 0.10¢
Trades for C:RVV on 20230825 - 143 trades displayed Time ET Ex Price Change Volume Buyer Seller Markers 12
...more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Aug 22, 2023 7:37am
$RVV Initiation of Novel Bucillamine Formulation Development
#Bucillamine https://ca.finance.yahoo.com/news/revive-therapeutics-announces-initiation-novel-103000575.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 22, 2023 6:30am
New Press Release - Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development
TORONTO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced that it has...
read article.
(408)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Aug 21, 2023 1:25pm
RVV ARE THE SHORTS IN PANIC MODE YET?
Shout out mei ole friend cool888 you still here hey bro?..it's aka moneynorthbound!! ya know the daze when kimkoosh lol was here!! anyways I was doing some dd on mei ole girlfriend here RVV
...more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Aug 11, 2023 1:49pm
Doctors Can Prescribe Ivermectin for COVID-19 - FDA Lawyer !
https://www.theepochtimes.com/article/doctors-can-prescribe-ivermectin-for-covid-19-fda-5456584
(12)
•••
Jackstock
X
View Profile
View Bullboard History
Post by
Jackstock
on Jul 28, 2023 9:09am
Better potential...
VEGA (PlantX).. Low share company 15m, good revenu last year and nice volume.
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jul 28, 2023 7:31am
$RVV - Update !
#Bucillamine https://ca.finance.yahoo.com/news/revive-therapeutics-announces-filing-patent-110000454.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 28, 2023 7:00am
New Press Release - Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents
TORONTO, July 28, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced that it has...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >